市場調查報告書
商品編碼
1467591
2024-2032 年 PET-CT 掃描儀設備市場報告(按類型、切片計數、同位素和探測器類型、服務提供者、應用程式和地區)PET-CT Scanner Device Market Report by Type, Slice Count, Isotope and Detector Type, Service Provider, Application, and Region 2024-2032 |
2023年,全球PET - CT掃描設備市場規模達22億美元。由於生活方式的改變和環境因素導致癌症盛行率上升,不斷增加的技術創新導致成像品質、效率和患者安全性提高,以及老年人口不斷成長,該市場正在經歷穩定成長。
市場成長與規模:由於醫療保健基礎設施的改善以及先進影像技術投資的增加,市場正在穩步成長。
技術進步:人工智慧 (AI) 演算法和多模態成像功能的整合正在增強診斷能力並簡化工作流程。
產業應用:PET-CT 掃描儀設備可用於心血管和神經系統疾病。
地理趨勢:在新醫院、診斷中心和專科診所數量不斷增加的推動下,亞太地區引領市場。然而,由於人們越來越意識到早期診斷的好處,北美正在成為一個快速成長的市場。
競爭格局:主要參與者正在投資研發 (R&D) 活動,以開發創新的 PET-CT 掃描儀技術,以提高影像能力、提高診斷準確性和病患舒適度。
挑戰與機會:雖然市場面臨初始成本高等挑戰,但隨著PET-CT影像應用的不斷擴大,也遇到了機會。
未來展望:隨著個人醫療保健需求的不斷變化,PET-CT 掃描儀設備市場的未來前景廣闊。此外,緊湊型攜帶式 PET-CT 掃描儀的不斷發展將使 PoC 成像成為可能,預計這將促進市場成長。
癌症病例盛行率上升
世界各地癌症盛行率的不斷上升正在推動 PET-CT 掃描儀設備市場的成長。 PET-CT 掃描儀在癌症診斷、分期和治療監測中發揮關鍵作用。透過 PET-CT 影像進行早期檢測可提高治療效果和患者預後,從而促進其廣泛採用。此外,醫療保健提供者越來越依賴 PET-CT 掃描來準確表徵疾病並制定個人化治療計劃。這些掃描利用癌細胞選擇性吸收的放射性藥物,實現腫瘤內代謝活動的可視化。同時,CT 掃描提供詳細的解剖影像,有助於精確定位 PET 檢測到的異常代謝活動。從 PET-CT 掃描獲得的全面資訊有助於腫瘤科醫師就治療策略(包括手術、放射治療、化療和標靶治療)做出明智的決定。此外,PET-CT 掃描可以迅速開始治療,並有可能改善患者的治療效果。人們越來越需要改善獲得先進診斷工具來對抗癌症的機會。
技術進步
PET-CT 掃描儀的創新有助於提高影像品質、效率和病患安全。現代 PET-CT 掃描儀具有更高的空間解析度,可更清晰地顯示小病灶,並提高腫瘤檢測和表徵的準確性。這項進步使得早期診斷和更精確的治療計劃成為可能。此外,先進的 PET-CT 掃描儀提供更短的掃描時間,有利於減少患者不適並提高醫療機構的工作流程效率。快速影像擷取使臨床醫生能夠在一段時間內執行更多掃描,從而提高患者吞吐量並提高資源利用率。此外,PET-CT 技術的進步導致了輻射劑量較低、同時保持診斷影像品質的掃描儀的開發。這些掃描儀透過最大限度地減少患者的輻射暴露,提高了安全性,並降低了與重複成像研究相關的長期不良影響的風險。除此之外,PET-CT 掃描儀採用先進的運動校正技術,例如呼吸門控和運動追蹤,可確保影像更清晰、無偽影。
老年人口增加
由於全球老年人口不斷增加,對 PET-CT 掃描儀設備的需求不斷成長,對市場產生了積極影響。老年人更容易患癌症、阿茲海默症、心血管疾病和其他慢性疾病,因此需要先進的設備來準確檢測和監測疾病。 PET-CT 掃描儀能夠全面評估心臟功能、心肌灌注和活力,有助於老年患者心血管疾病的診斷和管理。此外,老化與神經退化性疾病的風險增加有關。 PET-CT 影像為大腦代謝、澱粉樣蛋白沉積和神經受體結合提供了寶貴的見解,有助於老年人的早期診斷和疾病監測。除此之外,老年患者往往有多種合併症,需要全面的診斷評估。 PET-CT 掃描儀提供多模式影像功能,可在一次檢查中同時評估多個器官系統。這種綜合方法有利於簡化診斷工作流程並增強管理老年人複雜健康狀況的臨床決策。
The global PET-CT scanner device market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.
Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.
Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.
Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.
Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.
Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.
Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.
Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.
Rising prevalence of cancer cases
The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.
Technological advancements
Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.
Increasing geriatric population
The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, slice count, isotope and detector type, service provider, and application.
Stationary Scanners
Portable Scanners/Mobile Scanners
Stationary scanners account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes stationary scanners and portable scanners/mobile scanners. According to the report, stationary scanners represented the largest segment.
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
Medium slice scanner (64 slices) holds the largest market share
A detailed breakup and analysis of the market based on the slice count have also been provided in the report. This includes low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). According to the report, medium slice scanner (64 slices) accounted for the largest market share.
Flurodeoxyglucose (FDG)
62Cu ATSM
FMISO
Gallium
Thallium
Others
Flurodeoxyglucose (FDG) represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the isotope and detector type. This includes flurodeoxyglucose (FDG), 62Cu ATSM, 18 F sodium fluoride, FMISO, gallium, thallium, and others. According to the report, flurodeoxyglucose (FDG) represented the largest segment.
Hospitals
Diagnostic Centers
Research Institutes
Hospitals exhibit a clear dominance in the market
The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, diagnostic centers, and research institutes. According to the report, hospitals represented the largest segment.
Oncology
Neurology
Cardiology
Others
Oncology dominates the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, neurology, cardiology, and others. According to the report, oncology represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.
Bruker Corporation
Canon Medical Systems Usa Inc.
General Electric Company
Hitachi Ltd.
Koninklijke Philips N.V.
Mediso Ltd.
Neusoft Corporation
Positron Corporation
Shimadzu Corporation
Siemens Healthcare GmbH (Siemens AG)
Sofie Biosciences Inc.
United Imaging Healthcare Co. Ltd.
Yangzhou Kindsway Biotech Co. Ltd.